Search Results - "Xia, Tiansong"

Polycystin‐1 Mutant Alters Mechanotransduction in Response to Collagen and Extracellular Matrix Stiffness via Daam1‐Dependent Microfilament Remodeling.

Authors: Zhou, Jiaofeng Deng, Yibing Mei, Jie et al.

Source: Advanced Science; 11/6/2025, Vol. 12 Issue 41, p1-16, 16p

MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.

Authors: Zou, Xuan Xia, Tiansong Li, Minghui et al.

Source: Cancer Biomarkers. 2021, Vol. 30 Issue 1, p41-53. 13p.

Role of regulatory T cells and CD8⁺ T lymphocytes in the dissemination of circulating tumor cells in primary invasive breast cancer.

Authors: Xue, Dandan Xia, Tiansong Wang, Jue et al.

Source: Oncology Letters. Sep2018, Vol. 16 Issue 3, p3045-3053. 9p. 1 Black and White Photograph, 5 Charts, 1 Graph.

Preservation of thyroid cartilage mobility via lateral cervical approach mitigates anterior neck dysfunction following hemithyroidectomy.

Authors: Huang, Chengmin Wu, Junwei Xia, Tiansong

Source: European Archives of Oto-Rhino-Laryngology. May2026, Vol. 283 Issue 5, p3253-3261. 9p.

Predicting the sonication energy for focused ultrasound surgery treatment of breast fibroadenomas using machine learning algorithms.

Authors: Liang, Mengdi Liu, Yuelin Huang, Yue et al.

Source: International Journal of Hyperthermia. Dec2025, Vol. 42 Issue 1, p1-11. 11p.

A five‐miRNA panel in plasma was identified for breast cancer diagnosis.

Authors: Li, Minghui Zou, Xuan Xia, Tiansong et al.

Source: Cancer Medicine. Nov2019, Vol. 8 Issue 16, p7006-7017. 12p.

This result is not displayed to guests.
Login for full access.

Feasibility and efficacy of ultrasound-guided high-intensity focused ultrasound of breast fibroadenoma.

Authors: Liang, Mengdi Zhang, Zhizheng Zhang, Cai et al.

Source: International Journal of Hyperthermia. 2023, Vol. 40 Issue 1, p1-8. 8p.

Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1–7) as a sensitizer for chemotherapy and immunotherapy in breast cancer.

Authors: Mei, Jie Cai, Yun Xu, Rui et al.

Source: Biological Procedures Online. 10/25/2022, Vol. 24 Issue 1, p1-16. 16p.

Diagnostic value of oncofetal miRNAs in cancers: A comprehensive analysis of circulating miRNAs in pan-cancers and UCB.

Authors: Zhou, Xin Liu, Cheng Yin, Yin et al.

Source: Cancer Biomarkers. 2021, Vol. 32 Issue 1, p19-36. 18p.

LnNP@ZIF8 Smart System for In Situ NIR-II Ratiometric Imaging-Based Tumor Drug Resistance Evaluation.

Authors: Wang, Qingyuan Zhang, Zhizheng Qiu, Dehui et al.

Source: Nanomaterials (2079-4991). Dec2022, Vol. 12 Issue 24, p4478. 14p.

Subjects: Drug resistance, Reactive oxygen species, Targeted drug delivery, Metal-organic frameworks, Nanoparticles

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer.

Authors: Ma, Ge Wang, Jingyi Huang, Huaxing et al.

Source: Cancer Medicine. Apr2020, Vol. 9 Issue 7, p2271-2282. 12p.

Circulating plasma microRNA signature for the diagnosis of cervical cancer.

Authors: Ma, Ge Song, Guoxin Zou, Xuan et al.

Source: Cancer Biomarkers. 2019, Vol. 26 Issue 4, p491-500. 10p.

Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3A positive feedback loop.

Authors: Shi, Wanyue Tang, Tingting Li, Xinping et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 10/28/2019, Vol. 38 Issue 1, p1-20. 20p.

The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer.

Authors: Mei, Jie Cai, Yun Chen, Lingyan et al.

Source: British Journal of Cancer. Nov2023, Vol. 129 Issue 10, p1645-1657. 13p.

Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer.

Authors: Ma, Ge Huang, Huaxing Li, Minghui et al.

Source: Cancer Biomarkers. 2018, Vol. 22 Issue 3, p405-415. 11p.

Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.

Authors: Liu, Zhao Ren, Lidong Liu, Chenghao et al.

Source: PLoS ONE. Jun2015, Vol. 10 Issue 6, p1-16. 16p.

Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer.

Authors: Wang, Ji Wang, Xinyang Chen, Rui et al.

Source: International Journal of Clinical Oncology. May2022, Vol. 27 Issue 5, p889-898. 10p.

RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.

Authors: Wang, Mei Zhang, Yanyan Xu, Zhi et al.

Source: Cell Communication & Signaling. 8/17/2020, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p.

Comparative Profiling of Triple-Negative Breast Carcinomas Tissue Glycoproteome by Sequential Purification of Glycoproteins and Stable Isotope Labeling.

Authors: Chen, Xiang Wu, Jindao Huang, Huaxing et al.

Source: Cellular Physiology & Biochemistry (Karger AG). Jan2016, Vol. 38 Issue 1, p110-121. 12p.